Overview

COVID-19patients are at increased risk for thrombotic complications – this has led to an intense debate surrounding their anticoagulation management.

In the absence of data from randomized controlled clinical trials, experts have come together and a number of consensus guidelines and recommendations have been published to facilitate clinical decision making on this issue.

However substantive differences exist between these guidelines which can be difficult for clinicians.

This program will focus on VTE in COVID-19 patients. We will present cases that illustrate the importance of coordinated management of these patients, including need for appropriate thromboprophylaxis.

View or download the details in PDF format.

 

Supported by an educational grant from Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs,LLC

 

View All Speakers

Speakers

Edward Ryan, MD


Professor of Immunology and Infectious Diseases-Harvard T.H. Chan School of Public Health Professor of Medicine-Harvard Medical School Director of Global Infectious Diseases, Massachusetts General Hospital
View Full Bio

Kristen M. Sanfilippo, MD, MPHS


Assistant Professor of Medicine, Division of Hematology Washington University School of Medicine in St. Louis Staff Physician, Division of Hematology/Oncology, John Cochran Veterans Administration Medical Center St. Louis
View Full Bio

Rushad Patell, MD


Hematologist Beth Israel Deaconess Medical Center Boston, MA
View Full Bio

Behnood Bikdeli, MD, MS


Cardiovascular Medicine Division, Brigham and Women’s Hospital, Harvard Medical School Yale/ YNHH Center for Outcomes Research and Evaluation (CORE) Cardiovascular Research Foundation (CRF
View Full Bio

Lana Castellucci , MD FRCPC MSc


Assistant Professor, Faculty of Medicine University of Ottawa Scientist, The Ottawa Hospital Research Institute
View Full Bio

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and PERT Consortium. Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Boston University School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.